title: Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.
authors.affiliation: Hôpital Henri Mondor, Créteil, France.
authors.forename: P
authors.initials: P
authors.lastname: Chariot
authors.forename: R
authors.initials: R
authors.lastname: Abadia
authors.forename: D
authors.initials: D
authors.lastname: Agnus
authors.forename: C
authors.initials: C
authors.lastname: Danan
authors.forename: C
authors.initials: C
authors.lastname: Charpentier
authors.forename: R K
authors.initials: RK
authors.lastname: Gherardi
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives*; D017241:MELAS Syndrome / Q000209:etiology*; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications; D019821:Simvastatin
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D019821:Simvastatin